Sale of 913 shares at $44.33 per share.
Reporting Person KOCH KEVIN · Officer Title President and CEO · Transaction Code S
Traded Aug 12, 2026 · Disclosed Aug 14, 2026
Source: SEC Form 4 · 0001185829-26-000001 · filed 2026-08-14 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Edgewise Therapeutics, Inc. (EWTX)." Disclosed 2026-08-14. https://desqlong.com/cards/0001185829-26-000001-5 (retrieved 2026-09-26).